Assessing physical fitness in treatment-naive and ibrutinib-treated chronic lymphocytic leukemia (CLL) patients
Publication
, Conference
Sitlinger, A; Deal, M; Thompson, D; Stewart, T; Weinberg, JB; Bartlett, D; Brander, D
Published in: LEUKEMIA & LYMPHOMA
2020
Duke Scholars
Published In
LEUKEMIA & LYMPHOMA
EISSN
1029-2403
ISSN
1042-8194
Publication Date
2020
Volume
61
Start / End Page
224 / 225
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Sitlinger, A., Deal, M., Thompson, D., Stewart, T., Weinberg, J. B., Bartlett, D., & Brander, D. (2020). Assessing physical fitness in treatment-naive and ibrutinib-treated chronic lymphocytic leukemia (CLL) patients. In LEUKEMIA & LYMPHOMA (Vol. 61, pp. 224–225).
Sitlinger, Andrea, Michael Deal, Dana Thompson, Tiffany Stewart, J Brice Weinberg, David Bartlett, and Danielle Brander. “Assessing physical fitness in treatment-naive and ibrutinib-treated chronic lymphocytic leukemia (CLL) patients.” In LEUKEMIA & LYMPHOMA, 61:224–25, 2020.
Sitlinger A, Deal M, Thompson D, Stewart T, Weinberg JB, Bartlett D, et al. Assessing physical fitness in treatment-naive and ibrutinib-treated chronic lymphocytic leukemia (CLL) patients. In: LEUKEMIA & LYMPHOMA. 2020. p. 224–5.
Sitlinger, Andrea, et al. “Assessing physical fitness in treatment-naive and ibrutinib-treated chronic lymphocytic leukemia (CLL) patients.” LEUKEMIA & LYMPHOMA, vol. 61, 2020, pp. 224–25.
Sitlinger A, Deal M, Thompson D, Stewart T, Weinberg JB, Bartlett D, Brander D. Assessing physical fitness in treatment-naive and ibrutinib-treated chronic lymphocytic leukemia (CLL) patients. LEUKEMIA & LYMPHOMA. 2020. p. 224–225.
Published In
LEUKEMIA & LYMPHOMA
EISSN
1029-2403
ISSN
1042-8194
Publication Date
2020
Volume
61
Start / End Page
224 / 225
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences